日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Negative Descriptors of Patients With Sickle Cell Disease in the Electronic Health Record

电子健康记录中镰状细胞病患者的负面描述

Wesevich, Austin; Vangelatos, Alexandria; Sun, Michael; Tung, Elizabeth L; Peek, Monica E

Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies

复发/难治性急性白血病患者接受瑞伐美尼治疗后的疗效,重点关注瑞伐美尼治疗后的治疗效果

Thomas, Miles; Johnston, Hannah; Dworkin, Emily; Wesevich, Austin; Roloff, Gregory W; Saygin, Caner; Nawas, Mariam T; Drazer, Michael W; DuVall, Adam S; Kosuri, Satyajit; Thirman, Michael J; Odenike, Olatoyosi; Stock, Wendy; Larson, Richard A; Madero-Marroquin, Rafael; Patel, Anand A

Triaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratio

利用床旁SaO2/FiO2比值对急性胸痛综合征进行分诊临床决策

Wesevich, Austin; Woelkers, Megan; Adegunsoye, Ayodeji; Wesevich, Adam J; Ratain, Mark J; Lapping-Carr, Gabrielle

Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy

既往接受过维奈克拉治疗的髓系肿瘤患者接受化疗联合维奈克拉治疗后的疗效

Madero-Marroquin, Rafael; Cannova, Joseph; Dworkin, Emily; Wesevich, Austin; Roloff, Gregory W; Saygin, Caner; Nawas, Mariam T; DuVall, Adam S; Kosuri, Satyajit; Thirman, Michael J; Odenike, Olatoyosi; Stock, Wendy; Larson, Richard A; Drazer, Michael W; Patel, Anand A

An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States

美国对镰状细胞病基因疗法的伦理和经济义务

Wesevich, Austin; Peek, Monica E; Ratain, Mark J

Biased Language in Simulated Handoffs and Clinician Recall and Attitudes

模拟交班中的偏见性语言与临床医生的记忆和态度

Wesevich, Austin; Langan, Erica; Fridman, Ilona; Patel-Nguyen, Sonya; Peek, Monica E; Parente, Victoria

A Capstone Course for Senior Medical Students: from Innovative Elective to Required Core Curriculum

面向高年级医学生的毕业设计课程:从创新选修课到必修核心课程

Wesevich, Austin; De Fer, Thomas M; Awad, Michael M; Woodhouse, Julie; Andriole, Dorothy A; Brunt, L Michael

Do patent applications and Cooperative Research and Development Agreements between the National Cancer Institute and industry serve the public interest?

美国国家癌症研究所与工业界之间的专利申请和合作研发协议是否符合公众利益?

Wesevich, Austin; Ratain, Mark J

Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?

Optimus 项目:美国食品药品监督管理局是否豁免孤儿药的剂量优化?

Wesevich, Austin; Ratain, Mark J

Patient Factors Associated With Biased Language in Nightly Resident Verbal Handoff

与住院医师夜间口头交班中语言偏见相关的患者因素

Wesevich, Austin; Patel-Nguyen, Sonya; Fridman, Ilona; Langan, Erica; Parente, Victoria